Okyo Pharma

Okyo Pharma withdraws offer to sell shares after just 3 days citing 'changing market conditions'
Fierce Biotech
Mon, 07/31/23 - 11:38 am
Okyo Pharma
NASDAQ
With lung drug from Pfizer in hand, AN2 tests IPO waters in turbulent market
MedCity News
Tue, 03/8/22 - 10:01 am
AN2 Therapeutics
Okyo Pharma
IPOs
clinical trials
lung disease
dry eye disease